Publish Time: 2026-11-06 Origin: Site
Selecting a blood centrifuge for clinical research requires more than checking the maximum speed listed on a product page. The equipment, rotor and sample vessel must be assessed against every centrifugation stage specified by the study protocol.
This is particularly important for workflows involving plasma, serum and cell-free microRNA (cfmiRNA), where an initial centrifugation step may be followed by a higher-force second step.
A centrifuge's maximum RCF rating does not mean that every compatible rotor can reach the same centrifugal force. The achievable RCF depends on rotor geometry, effective radius and operating speed.
Different rotor designs have different effective radii and permitted speed limits. A swing-out rotor and a fixed-angle rotor installed on the same centrifuge may therefore have different maximum RCF values and sample capacities.
| YT5R configuration | Maximum speed | Maximum RCF |
|---|---|---|
| Main unit rating | 5,000 rpm | 4,730 ×g |
| D5-4 · 4 × 13 × 10 mL | 4,000 rpm | 2,830 ×g |
| D5-23 · 24 × 15 mL | 5,000 rpm | 3,500 ×g |
| D5-24 · 30 × 15 mL | 5,000 rpm | 3,830 ×g |
Before ordering, confirm the required RCF, rotor model, permitted speed, vessel compatibility, adapter and actual capacity per run.
Some blood-processing methods use more than one centrifugation stage. The first stage separates the initial plasma or serum fraction. A second stage may be specified to further reduce residual platelets and cellular material.
The National Cancer Institute's evidence-based procedure Cell-Free miRNA: Blood Collection and Processing describes protocol-specific processing conditions.
1–20 minutes · 4°C or room temperature, depending on the validated collection-tube method.
15 minutes · specified in the relevant cfmiRNA processing procedure when further platelet removal is required.
These values are not universal settings for all blood samples or clinical research studies. The required method depends on the sample type, collection tube and research objective.
The NCI procedure also notes that additional centrifugation can affect recovery of low-abundance cfmiRNA. A second stage should therefore be included only when required by the applicable study method.
Once the required centrifugation stages, sample vessels and operating conditions are defined, the equipment and rotor configuration can be evaluated.
A refrigerated platform with multiple rotor options for different blood-tube and laboratory applications.
D5-4: 4 × 13 × 10 mL, 2,830 ×g.
D5-23: 24 × 15 mL, 3,500 ×g.
A refrigerated blood centrifuge platform with swing-out and fixed-angle rotor configurations.
5A-3: 4 × 18 × 10 mL, 3,140 ×g.
5A-10: 24 × 15 mL, 3,500 ×g.
5A-11: 30 × 15 mL, 3,830 ×g.
A higher-speed refrigerated platform for applications requiring greater centrifugal force with the corresponding high-speed rotor.
G16-15: 12 × 15 mL, 11,840 ×g.
G16-14: 12 × 10 mL, 14,510 ×g.
G16-13: 6 × 10 mL, 16,460 ×g.
Main-unit and rotor ratings are separate specifications. The listed rotor capacities and RCF values apply only to their stated configurations. Confirm the current product specification and supplied accessories before ordering.
Tube capacity alone is not enough to establish compatibility. Tube diameter, length, material, cap design and adapter requirements all affect the selected rotor configuration.
GlanLab's published blood-tube rotor options illustrate how the maximum RCF can vary between configurations.
| Platform | Rotor | Sample configuration | Maximum RCF |
|---|---|---|---|
| YT5R | D5-17 | 4 × 12 × 5 mL | 2,480 ×g |
| YT5R | D5-18 | 4 × 12 × 7 mL | 2,760 ×g |
| YT5R | D5-19 | 4 × 10 × 10 mL | 2,880 ×g |
| YT5AR | 5A-7 | 4 × 12 × 5 mL | 2,480 ×g |
| YT5AR | 5A-7 | 4 × 12 × 7 mL | 2,760 ×g |
| YT5AR | 5A-7 | 4 × 12 × 10 mL | 2,790 ×g |
For example, a 2,000 ×g requirement falls within the listed maximum RCF of these configurations. A 2,800 ×g requirement exceeds the listed limits of the 5 mL and 7 mL configurations above.
Different centrifuge models may be used across research sites, but identical headline RCF values do not establish equivalent sample-processing conditions.
Rotor design, sample vessel, acceleration and deceleration settings, temperature and run time may all affect the processing method. Any equipment differences that could influence the method should be evaluated and documented against the approved study procedure.
The NCI's Best Practices for Biospecimen Resources emphasizes standardized biospecimen handling and quality management. For multi-site projects, the study protocol and validated processing method should define which equipment differences are acceptable.
A request for quotation should describe the actual processing requirements rather than only naming a centrifuge type or maximum speed.
| RFQ item | Information to provide |
|---|---|
| Research application | Clinical research, blood processing or biobanking |
| Sample type | Plasma, serum or other sample |
| Tube manufacturer | Manufacturer and exact tube model |
| Tube dimensions | Diameter, length and nominal volume |
| Centrifugation stages | Single-stage or multi-stage workflow |
| Required RCF | Target RCF for each stage |
| Run time | Duration for each stage |
| Temperature | Required temperature or ambient processing |
| Rotor | Swing-out or fixed-angle, if specified |
| Batch capacity | Number of samples per run |
| Operating settings | Acceleration and deceleration requirements |
| Order details | Quantity and destination country |
Multi-site projects should also specify equipment quantities by location, configuration consistency requirements and any required product documentation.
Send your sample tube specifications, required RCF for each processing stage, temperature and batch capacity. GlanLab can assess the available centrifuge and rotor configurations for your quotation.
Submit Your Requirements →Not necessarily. Different processing stages may require different RCF ranges. Check the maximum RCF of the exact rotor and vessel configuration for every stage.
No. The selected rotor must reach the required RCF with the specified sample vessel. A main-unit maximum rating does not establish the capability of every rotor.
No. Refrigeration should be selected according to the approved sample-processing method and its temperature requirements.
Potentially. Equipment and rotor configurations must be assessed against the same approved processing requirements, with relevant differences evaluated and documented.
Selecting a blood centrifuge for clinical research starts with the complete sample-processing workflow. Every centrifugation stage must be checked against the actual equipment, rotor and vessel configuration.
For multi-stage workflows, the initial and secondary processing steps may have substantially different RCF requirements. Selecting a centrifuge based on only one stage can leave the remaining process unsupported.
GlanLab offers centrifuge platforms with different speed, capacity and temperature-control capabilities, together with swing-out and fixed-angle rotor options.
Send your sample tube specifications, required RCF for each processing stage and batch capacity to GlanLab for an equipment and rotor configuration assessment.